Insights: News
As a diagnostics platform company that provides serious or complex laboratory testing, Mayo Clinic Laboratories is constantly working to advance patient care and broaden access to specialized testing. Learn about the latest news from Mayo Clinic Laboratories here, including new test launches, collaborations, operational updates, and more.
Most recent posts
In the second quarter of 2026, Mayo Clinic Laboratories expanded its test catalog with several innovative new tests.
Mayo Clinic’s Advanced Diagnostics Laboratory researchers are using phage immunoprecipitation sequencing to discover new serological biomarkers for autoimmune diseases.
The New England Journal of Medicine recently published new findings on periprosthetic joint infection by Dr. Robin Patel.
Topic highlights include: Phoenix Children’s opens specialty clinic at Avondale campus, Moderna says RSV vaccine is effective in older adults, WHO questions severity of XBB.1.5 COVID subvariant as U.S. cases rise
Together, Mayo Clinic Laboratories and Helix will provide biopharma customers with a full spectrum of testing capabilities and end-to-end laboratory testing support.
Education on this topic decreases misdiagnosis and the possibility of misinterpreting the comments provided by the reporting laboratories.
Topic highlights include: With attention to mpox fading, health officials fear infections will go undetected and unreported, As COVID surges in China, US begins testing more travelers, FDA approves Alzheimer's drug that appears to modestly slow disease
Mayo Clinic Laboratories is excited to announce our participation in Medlab Middle East 2023, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 6–9, 2023.
Mayo Clinic Laboratories, a leader in gastroenterology and patient care, will be exhibiting at the Crohn's & Colitis Congress, a premier conference for health care professionals and researchers interested in inflammatory bowel disease (IBD). Mayo Clinic Laboratories offers a comprehensive IBD test menu, including evaluations to diagnose, differentiate, and manage therapies to treat the condition.
Topic highlights include: Public health agencies try to restore trust as they fight misinformation, Telehealth brings expert sexual assault exams to rural patients, FDA decision on experimental Alzheimer’s drug expected this week.
In December 2022, Mayo Clinic Laboratories announced seventy-eight new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Due to logistic challenges, we are experiencing shipment delays which may result in testing delays or cancelations.
The MayoComplete Liquid Biopsy Panel offers a noninvasive alternative to traditional cell-based biopsies. This allow for faster turnaround time and the ability to perform molecular DNA testing in cancer patients where tumor tissue isn’t available.